Inventor · disambiguated record
Michael Mark
Also filed as: MARK MICHAEL
49 granted patents·84 pending applications·1,716 citations·filing 1989–2024
99Inventor score
Files withBOEHRINGER INGELHEIM INT65BOEHRINGER INGELHEIM PHARMA18HIMMELSBACH FRANK10KLEIN THOMAS10THOMAE GMBH DR K6
Top patents by PatentIndex Score
133 records- 0199US8178541B28-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositionsHIMMELSBACH FRANK·Filed 2008·Granted May 15, 2012·104 cites·48 claims
- 0299US8119648B28-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositionsHIMMELSBACH FRANK·Filed 2008·Granted Feb 21, 2012·101 cites·10 claims
- 0398US9321791B28-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Apr 26, 2016·26 cites·4 claims
- 0498US8673927B2Uses of DPP-IV inhibitorsDUGI KLAUS·Filed 2010·Granted Mar 18, 2014·63 cites·26 claims
- 0598US8664232B28-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositionsHIMMELSBACH FRANK·Filed 2012·Granted Mar 4, 2014·42 cites·15 claims
- 0698US8232281B2Uses of DPP-IV inhibitorsDUGI KLAUS·Filed 2007·Granted Jul 31, 2012·110 cites·47 claims
- 0798US7407955B28-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Aug 5, 2008·160 cites·21 claims
- 0898US7109192B2Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Sep 19, 2006·130 cites·9 claims
- 0996US9186392B2Combination therapyKLEIN THOMAS·Filed 2011·Granted Nov 17, 2015·52 cites·4 claims
- 1096US9173859B2Uses of DPP IV inhibitorsDUGI KLAUS·Filed 2014·Granted Nov 3, 2015·27 cites·22 claims
- 1196US8551957B2Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivateDUGI KLAUS·Filed 2008·Granted Oct 8, 2013·53 cites·48 claims
- 1296US7838529B2Xanthine derivates, their preparation and their use in pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2009·Granted Nov 23, 2010·52 cites·20 claims
- 1396US7482337B2Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jan 27, 2009·86 cites·9 claims
- 1496US6617325B1Biphenyl derivatives, production thereof and uses as medicinesBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Sep 9, 2003·121 cites·8 claims
- 1595US9149478B2Diabetes therapyKLEIN THOMAS·Filed 2011·Granted Oct 6, 2015·36 cites·8 claims
- 1695US7495005B2Xanthine derivatives, their preparation and their use in pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Feb 24, 2009·67 cites·10 claims
- 1794US9034883B2Vasoprotective and cardioprotective antidiabetic therapyKLEIN THOMAS·Filed 2011·Granted May 19, 2015·53 cites·5 claims
- 1894US7566707B2Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2004·Granted Jul 28, 2009·65 cites·19 claims
- 1993US12115179B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2023·Granted Oct 15, 2024·1 cites·24 claims
- 2093US9457029B2Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptinDUGI KLAUS·Filed 2010·Granted Oct 4, 2016·29 cites·15 claims
- 2193US7569574B2Purine derivatives, the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Aug 4, 2009·65 cites·14 claims
- 2293US7560450B2Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jul 14, 2009·65 cites·15 claims
- 2391US10406172B2Pharmaceutical composition, methods for treating and uses thereofEICKELMANN PETER·Filed 2013·Granted Sep 10, 2019·26 cites·29 claims
- 2491US7696212B2Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2008·Granted Apr 13, 2010·14 cites·8 claims
- 2591US2025064819A1Uses of dpp iv inhibitorsBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2690US10092571B2Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptinBOEHRINGER INGELHEIM INT·Filed 2016·Granted Oct 9, 2018·9 cites·9 claims
- 2789US8513264B2Combination therapy for the treatment of diabetes and related conditionsMARK MICHAEL·Filed 2009·Granted Aug 20, 2013·37 cites·21 claims
- 2887US2024299399A1Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndromeBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2986US11911388B2Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drugBOEHRINGER INGELHEIM INT·Filed 2021·Granted Feb 27, 2024·1 cites·11 claims
- 3085US6821967B2Substituted piperazine derivatives, the preparation thereof and their use as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Nov 23, 2004·24 cites·7 claims
- 3184US2024335514A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3283US12171767B2Uses of DPP IV inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Dec 24, 2024·0 cites·19 claims
- 3383US2024156823A1Vasoprotective and cardioprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3481US9526730B2Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndromeBOEHRINGER INGELHEIM INT·Filed 2015·Granted Dec 27, 2016·3 cites·13 claims
- 3579US10004747B2Combination therapyBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jun 26, 2018·2 cites·4 claims
- 3678US5455273AN,N-disubstituted arylcycloalkylamines, the salts thereof, pharmaceutical compositions containing these compounds and the use thereof and processes for preparing themTHOMAE GMBH DR K·Filed 1993·Granted Oct 3, 1995·37 cites·2 claims
- 3777US2025082642A1Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drugBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3876US12312352B2Use of a DPP-4 inhibitor in SIRS and/or sepsisBOEHRINGER INGELHEIM INT·Filed 2022·Granted May 27, 2025·0 cites·8 claims
- 3976US6818644B1Substituted piperazine derivatives, the preparation thereof and their use as medicamentsBOEHRINGER INGELHEIM PHARM GMB·Filed 2000·Granted Nov 16, 2004·14 cites·10 claims
- 4076US2021379073A1Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndromeBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 4175US2024148737A1Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drugBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 4274US2021283156A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 4373US11911387B2Vasoprotective and cardioprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2020·Granted Feb 27, 2024·0 cites·3 claims
- 4473US11291668B2Uses of DPP IV inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Apr 5, 2022·0 cites·1 claims
- 4573US2022152159A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 4672US5466687AArylidene-1-azacycloalkanes and arylalkyl-1-azacyclo-alkanes, their salts, medicaments containing these compounds and their use, and processes for their preparationTHOMAE GMBH DR K·Filed 1994·Granted Nov 14, 1995·14 cites·17 claims
- 4771US2021346415A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 4870US2011112069A1Purin derivatives for use in the treatment of fab-related diseasesBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 4969US2018353513A1Uses of dpp iv inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 5069US2020069713A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
Showing the top 50 of 133 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Mark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →